We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+3.64%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$74.9B
AUM Growth
+$9.23B
(+14%)
Cap. Flow
+$7.27B
Cap. Flow
% of AUM
9.7%
Top 10 Holdings %
Top 10 Hldgs %
32.66%
Holding
3,137
New
748
Increased
792
Reduced
857
Closed
654
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$3.04B |
| 2 |
Microsoft
MSFT
|
+$830M |
| 3 |
Amazon
AMZN
|
+$550M |
| 4 |
Johnson & Johnson
JNJ
|
+$483M |
| 5 |
Apple
AAPL
|
+$470M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$474M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$435M |
| 3 |
Vanguard S&P 500 ETF
VOO
|
+$428M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$371M |
| 5 |
Micron Technology
MU
|
+$275M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 18.7% |
| 2 | Consumer Discretionary | 13.75% |
| 3 | Healthcare | 12.4% |
| 4 | Financials | 7.81% |
| 5 | Industrials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
IVCAW
1076
CALL
DELISTED
Investcorp AI Acquisition Corp. Warrant
IVCAW
| $3.98M | 0.01% |
349,999
| – | – |
|
1077
Heritage Insurance Holdings
HRTG
$903M
| $3.97M | 0.01% |
560,353
-16,934
| -3% | -$150K |
|
|
HIMX
1078
Himax Technologies
HIMX
$2.03B
| $3.96M | 0.01% |
499,046
-276,794
| -36% | -$1.69M |
|
|
WNS
1079
DELISTED
WNS Holdings
WNS
| $3.92M | 0.01% |
74,753
-559,774
| -88% | -$27.7M |
|
1080
Viking Therapeutics
VKTX
$3.88B
| $3.91M | 0.01% |
73,700
-297,986
| -80% | -$19.5M |
|
1081
MaxLinear
MXL
$5.19B
| $3.9M | 0.01% |
193,883
+71,512
| +58% | +$1.41M |
|
1082
First Majestic Silver
AG
$7.52B
| $3.9M | 0.01% |
+659,437
| New | +$4.57M |
|
|
FLDDW
1083
CALL
Fold Holdings Warrant
FLDDW
$995K
| $3.9M | 0.01% |
356,086
| – | – |
|
|
VZIO
1084
DELISTED
VIZIO Holding Corp.
VZIO
| $3.9M | 0.01% |
361,272
-245,657
| -40% | -$2.63M |
|
1085
4D Molecular Therapeutics
FDMT
$502M
| $3.9M | 0.01% |
185,866
-71,880
| -28% | -$1.8M |
|
1086
Genesco
GCO
$434M
| $3.89M | 0.01% |
150,494
-26,030
| -15% | -$682K |
|
1087
Turning Point Brands
TPB
$1.48B
| $3.85M | 0.01% |
119,954
+367
| +0.3% | +$11.3K |
|
1088
VTEX
VTEX
$767M
| $3.85M | 0.01% |
529,944
-68,284
| -11% | -$495K |
|
1089
ALX Oncology
ALXO
$262M
| $3.83M | 0.01% |
635,679
+514,133
| +423% | +$6.32M |
|
1090
iShares 20+ Year Treasury Bond ETF
TLT
$42.4B
| $3.82M | 0.01% |
41,667
-63,075
| -60% | -$5.75M |
|
1091
Rollins
ROL
$18.6B
| $3.79M | 0.01% |
+77,635
| New | +$3.58M |
|
1092
Barclays
BCS
$87.8B
| $3.77M | 0.01% |
352,397
-5,045,770
| -93% | -$52.5M |
|
1093
First Financial Bankshares
FFIN
$5.05B
| $3.77M | 0.01% |
127,782
+21,020
| +20% | +$629K |
|
1094
California Water Service
CWT
$3.1B
| $3.73M | 0.01% |
76,851
+59,956
| +355% | +$2.91M |
|
1095
Southern Copper
SCCO
$138B
| $3.72M | 0.01% |
36,882
+20,154
| +120% | +$2.14M |
|
1096
SBA Communications
SBAC
$19.8B
| $3.72M | 0.01% |
18,953
-190,247
| -91% | -$37.6M |
|
1097
Haemonetics
HAE
$3.88B
| $3.71M | 0.01% |
44,892
-36,503
| -45% | -$3.21M |
|
1098
Emergent Biosolutions
EBS
$379M
| $3.7M | ﹤0.01% |
542,813
+233,341
| +75% | +$1M |
|
1099
Matsons
MATX
$6.11B
| $3.7M | ﹤0.01% |
+28,250
| New | +$3.28M |
|
1100
Warner Bros
WBD
$64.3B
| $3.7M | ﹤0.01% |
497,200
-1,425,384
| -74% | -$11.4M |
|
Similar funds
Marshall Wace's Q2 2024 Portfolio in Review
As of Q2 2024, Marshall Wace held 3,137 positions worth $74.9B, up 14% from $65.7B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
Marshall Wace deployed $7.27B of net new capital in Q2 2024, opening 748 new positions and adding to 792 existing holdings. Its largest new stake was GE Vernova: 2,330,887 shares worth $400M.
By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 16% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Procter & Gamble, an estimated $474M trimmed.
- Marshall Wace's largest Q2 2024 buy was GE Vernova: 2,330,887 shares worth $400M.
- Marshall Wace added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $3.04B increase.
- Marshall Wace's biggest Q2 2024 reduction was Procter & Gamble, cutting an estimated $474M.
- Marshall Wace fully exited Applied Materials in Q2 2024, selling an estimated $127M.
- Marshall Wace's ten largest holdings make up 33% of its $74.9B portfolio in Q2 2024.
- Marshall Wace opened 748 new positions and closed 654 in Q2 2024.
- Marshall Wace's portfolio value rose 14% quarter-over-quarter to $74.9B.
Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.